Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 21 July 2000:
Vol. 289. no. 5478, pp. 382 - 383
DOI: 10.1126/science.289.5478.382

News Focus

BIOTERRORISM:
DOD Retreats on Plan for Anthrax Vaccine

Eliot Marshall

Anthrax bacterium, once the deadly scourge of goat-hair workers, has become the bane of the U.S. defense establishment. Without infecting a single soldier, it has created a logistical headache for the Pentagon, as military contractors have fallen far short of supplying a vaccine that will protect all troops and be acceptable to health authorities. Last week military officials were forced to beat a hasty retreat in their current efforts, raising the hackles of legislators who already had serious doubts about the program.

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Dominant Negative Mutant of Bacillus anthracis Protective Antigen Inhibits Anthrax Toxin Action in Vivo.
Y. Singh, H. Khanna, A. P. Chopra, and V. Mehra (2001)
J. Biol. Chem. 276, 22090-22094
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)